Rebecca Lehto on Complementary Modalities During Lung Cancer Treatment

Article

Rebecca Lehto, PhD, RN, OCN, discusses patient use of complementary modalities during treatment for advanced lung cancer.

Rebecca Lehto, PhD, RN, OCN, assistant professor, College of Nursing, Michigan State University, discusses patient use of complementary modalities during treatment for advanced lung cancer.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
4 experts in this video
4 experts in this video
Photo of a man wearing glasses and a suit in front of a blue background
Related Content
Graphic of a person with tumors in their right lung

ZEN-3694 Receives FDA Fast Track Status in Metastatic NUT Carcinoma

Russ Conroy
July 23rd 2025
Article

The investigational BET inhibitor is being investigated combined with abemaciclib or cisplatin/etoposide in NUT carcinoma in 2 clinical trials.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

Lindsay Fischer
November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Photo of the FDA office's sign

Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

Bridget Hoyt
July 2nd 2025
Article

Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Graphic of a pair of lungs with tumors

ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

Roman Fabbricatore
July 1st 2025
Article

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.

Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.